Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
alzheimer's disease
3
×
biogen
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
bristol-myers squibb
clinical trials
3
×
detroit blog main
detroit top stories
indiana blog main
indiana top stories
life sciences
national
national blog main
national top stories
new york blog main
new york top stories
nonalcoholic steatohepatitis
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
abbvie
aducanumab
affordable care act
biotech
cancer
cancer immunotherapy
deals
eisai
eli lilly
What
bio
drug
3
×
roundup
alzheimer’s
biogen’s
nash
news
week
aducanumab
amyloid
angst
annual
approval
assessed
attention
bagged
billions
biogen
biopharmaceutical
biotech
brammer
communities
companies
conference
convo
earlier
effects
esmo
europe
failure
failures
felt
germany
hosted
investment
littered
lost
munich
new
price
Language
Current search:
drug
×
" clinical trials "
×
" alzheimer's disease "
×
@xconomy.com
5 years ago
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More
@xconomy.com
5 years ago
Bio Roundup: Amyloid Angst, NASH News, Brammer Bagged & More
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Puzzle, ESMO Assessed, Drug Prices & More